ArticleViruses2022

Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2).

Wendimi Fatimata Belem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.